US Drug Recall Register
Class III · Low risk Terminated Initiated Oct 18, 2021 (5 years ago)

Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, 12 Tablets (2 x 6 Unit-Dose…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.

What was recalled

Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, 12 Tablets (2 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macleods Pharma USA Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-093-41

Recalling firm
Macleods Pharma USA, INC
NDC code
33342-093-41
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0079-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Rizatriptan recalls

See all